genomic datasets
M2Gen Lands New Private Investment, Inks Research Deal with Merck
Bioinformatics firm M2Gen will provide Merck with deidentified clinical and genomics data to aid in oncology drug discovery and development.
Adaptive Biotechnologies, AstraZeneca Collaborate on Mapping Immune Response in Cancer
The partners will use Adaptive's ImmunoSeq T-Map technology to analyze immune response to cancer antigens across AstraZeneca's oncology portfolio.
Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan
The firm also provided preliminary revenues of $950 million for Q4 and reinstated guidance of $3.79 billion to $3.88 billion for 2021.
Informaticians from Georgetown and other major cancer centers expect their technology to bring precision oncology services to community hospitals and clinics.
Pediatric Cancer Researchers, Clinicians Look to Enhance Molecular Data Collection, Distribution
At the NCI's Childhood Cancer Data Initiative Symposium, speakers emphasized measures such as data harmonization and the need for longitudinal data collection.
May 14, 2019
May 2, 2019